BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioMidwest

  U.S. EPA Approves Expanded Use of LEAP® ES Bacterial Disease Management Biological Insecticide from Valent BioSciences

  Valent BioSciences has announced that the U.S. EPA (Environmental Protection Agency) has approved the expanded use of LEAP® ES Bacterial Disease Management Biological Insecticide.

  February 1, 2022

   · 

  1 min read
• BioMidwest

  CND Life Sciences Closes Series Seed 2 Round, Reaches $8 Million In Total Capital Raised

  CND Life Sciences, Inc., an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, announced the closing of a $5.0 million Series Seed 2 financing round.

  February 1, 2022

   · 

  4 min read
• Business

  Pfizer Announces New Chief Development Officer

  Pfizer Inc. (NYSE: PFE) today announced that William Pao, M.D., Ph.D., will join the Company as Executive Vice President and Chief Development Officer effective March 21, 2022.

  February 1, 2022

   · 

  5 min read
• Business

  Dr. Barbara Alexander Joins HealthTrackRx Advisory Board

  HealthTrackRx, the nation’s leading polymerase chain reaction testing lab, announced Barbara Alexander, MD, MHS, who recently served as President of the Infectious Diseases Society of America, has joined its advisory board.

  February 1, 2022

   · 

  2 min read
• Business

  Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022

  Organon (NYSE: OGN), will release its fourth quarter and full year 2021 financial results on February 17, 2022, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.

  February 1, 2022

   · 

  2 min read
• Business

  OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022, after the market closes.

  February 1, 2022

   · 

  1 min read
• Drug Development

  Arcutis Completes Enrollment of STRATUM Pivotal Phase 3 Trial of Topical Roflumilast Foam in Individuals with Seborrheic Dermatitis

  Arcutis Biotherapeutics, Inc. today announced the enrollment of the last subject its STRATUM phase 3 pivotal trial for topical roflumilast foam in patients with seborrheic dermatitis.

  February 1, 2022

   · 

  5 min read
• Business

  Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases

  Sarepta and GenEdit will work together to identify development candidates for further testing.

  February 1, 2022

   · 

  7 min read
• Pharm Country

  Jasper Health Raises $25 Million in Series A Funding to Increase Access to Comprehensive Cancer Experience and Care Navigation Platform

  Jasper Health today announced a $25 million Series A funding round led by General Catalyst.

  February 1, 2022

   · 

  4 min read
• Business

  Ontario Bioscience Innovation Organization Welcomes Dr. Maura Campbell as Incoming CEO

  Outgoing CEO Gail Garland to consult with OBIO for successful transition of not-for-profit.

  February 1, 2022

   · 

  3 min read